InfuSystem (INFU) Announces Quarterly Earnings Results

InfuSystem (NYSEAMERICAN:INFU) posted its earnings results on Tuesday. The medical instruments supplier reported ($0.05) EPS for the quarter, Morningstar.com reports. The business had revenue of $18.19 million for the quarter.

Shares of InfuSystem stock traded down $0.04 on Wednesday, hitting $4.59. The company had a trading volume of 525 shares, compared to its average volume of 27,823. InfuSystem has a 52 week low of $2.80 and a 52 week high of $5.21.

In related news, Director Scott Shuda acquired 11,224 shares of the firm’s stock in a transaction dated Wednesday, March 20th. The stock was acquired at an average cost of $4.37 per share, for a total transaction of $49,048.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Christopher R. Sansone acquired 25,000 shares of the firm’s stock in a transaction dated Monday, March 18th. The stock was bought at an average price of $4.36 per share, with a total value of $109,000.00. The disclosure for this purchase can be found here. Insiders bought 40,124 shares of company stock valued at $174,507 over the last quarter.

Institutional investors have recently bought and sold shares of the company. Price Wealth Management Inc. acquired a new stake in InfuSystem during the fourth quarter valued at approximately $688,000. Dimensional Fund Advisors LP lifted its stake in InfuSystem by 23.3% during the third quarter. Dimensional Fund Advisors LP now owns 212,240 shares of the medical instruments supplier’s stock valued at $690,000 after purchasing an additional 40,041 shares during the last quarter. Renaissance Technologies LLC lifted its stake in InfuSystem by 13.2% during the third quarter. Renaissance Technologies LLC now owns 301,096 shares of the medical instruments supplier’s stock valued at $979,000 after purchasing an additional 34,996 shares during the last quarter. FineMark National Bank & Trust lifted its stake in InfuSystem by 5.9% during the first quarter. FineMark National Bank & Trust now owns 225,396 shares of the medical instruments supplier’s stock valued at $1,129,000 after purchasing an additional 12,500 shares during the last quarter. Finally, White Pine Capital LLC lifted its stake in InfuSystem by 26.7% during the first quarter. White Pine Capital LLC now owns 401,250 shares of the medical instruments supplier’s stock valued at $2,010,000 after purchasing an additional 84,575 shares during the last quarter.

TRADEMARK VIOLATION WARNING: This article was first posted by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this article on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The original version of this article can be viewed at https://www.baseballdailydigest.com/news/2019/05/15/infusystem-infu-announces-quarterly-earnings-results.html.

InfuSystem Company Profile

InfuSystem Holdings Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

Featured Article: Gap Up Stocks

Earnings History for InfuSystem (NYSEAMERICAN:INFU)

Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.